Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (731-740 of 13,985) with videos related to

Pageof 1,399
Sort By:
Leukemia|November 1, 1996
Activation of T cell cytotoxicity against autologous common acute lymphoblastic leukemia (cALL) blasts by CD3xCD19 bispecific antibodyM Csóka, G Strauss, K M Debatin, et al.
Leukemia|November 1, 1996
Inhibition of apoptotic cell death in B-CLL by interferon gamma correlates with clinical stageR Rojas, J Roman, A Torres, et al.
Leukemia|November 1, 1996
Purification of repopulating hemopoietic cells based on binding of biotinylated Kit ligandM O de Jong, H Rozemuller, D Kieboom, et al.
Leukemia|November 1, 1996
A third case of apparent t(2;4)(p23;q25) represents ins(2;4) with deletion of 2pK E Richkind, A Lamb, C Lytle, et al.
Leukemia|May 16, 2015
Reduced-intensity transplants, conventional transplants or chemotherapy for acute myeloid leukemia in 1st remission: who knows; ask your wife?R P Gale
Leukemia|May 7, 2015
The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemiaJ Eswaran, P Sinclair, O Heidenreich, et al.
Leukemia|May 3, 2020
Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemiaStefanos A Bamopoulos, Aarif M N Batcha, Vindi Jurinovic, et al.
Leukemia|May 14, 2020
Contribution of CTCF binding to transcriptional activity at the HOXA locus in NPM1-mutant AML cellsReza Ghasemi, Heidi Struthers, Elisabeth R Wilson, et al.
Leukemia|May 14, 2020
Good prognosis or poor prognosis, dose-intensive or less intensive: who decides for adults with T-lymphoblastic lymphoma/leukemiaKen H Young
Leukemia|May 14, 2020
Soluble SLAMF7 is a predictive biomarker for elotuzumab therapyAtsushi Suzuki, Satoshi Kakugawa, Masafumi Miyoshi, et al.
Pageof 1,399

Showing results (731-740 of 13,985) with videos related to

Sort By:
Pageof 1,399
Leukemia|November 1, 1996
Activation of T cell cytotoxicity against autologous common acute lymphoblastic leukemia (cALL) blasts by CD3xCD19 bispecific antibodyM Csóka, G Strauss, K M Debatin, et al.
Leukemia|November 1, 1996
Inhibition of apoptotic cell death in B-CLL by interferon gamma correlates with clinical stageR Rojas, J Roman, A Torres, et al.
Leukemia|November 1, 1996
Purification of repopulating hemopoietic cells based on binding of biotinylated Kit ligandM O de Jong, H Rozemuller, D Kieboom, et al.
Leukemia|November 1, 1996
A third case of apparent t(2;4)(p23;q25) represents ins(2;4) with deletion of 2pK E Richkind, A Lamb, C Lytle, et al.
Leukemia|May 16, 2015
Reduced-intensity transplants, conventional transplants or chemotherapy for acute myeloid leukemia in 1st remission: who knows; ask your wife?R P Gale
Leukemia|May 7, 2015
The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemiaJ Eswaran, P Sinclair, O Heidenreich, et al.
Leukemia|May 3, 2020
Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemiaStefanos A Bamopoulos, Aarif M N Batcha, Vindi Jurinovic, et al.
Leukemia|May 14, 2020
Contribution of CTCF binding to transcriptional activity at the HOXA locus in NPM1-mutant AML cellsReza Ghasemi, Heidi Struthers, Elisabeth R Wilson, et al.
Leukemia|May 14, 2020
Good prognosis or poor prognosis, dose-intensive or less intensive: who decides for adults with T-lymphoblastic lymphoma/leukemiaKen H Young
Leukemia|May 14, 2020
Soluble SLAMF7 is a predictive biomarker for elotuzumab therapyAtsushi Suzuki, Satoshi Kakugawa, Masafumi Miyoshi, et al.
Pageof 1,399